Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Rebates, Impact On Premiums Must Be Disclosed Under COVID Stimulus Law

Dec 30 2020

• By Cathy Kelly

New Drug Price Discounting And Reporting Requirements

Related Content

Medicare Walks Back Proposed Payment Policy For 505(b)(2) Physician Administered Drugs

Dec 02 2020

The Rebate Rule May Not Last, But It Changed The Pricing Debate

Dec 01 2020

Happy Holidays: ‘Most Favored Nation’ Rule Effective Date Likely To Be Delayed

Dec 22 2020

How A Medicare Payment ‘Loophole’ Boosts Spending On Orencia, Cimza

Jul 16 2020

340B And US Drug Pricing: Trump’s First Target Is One That Lasts

Aug 06 2020

Related Companies

Bristol Myers Squibb Company

UCB S.A.

Anika Therapeutics, Inc.

Johnson & Johnson

Zimmer Biomet Holdings, Inc.

Additional Topics

United States Reimbursement Pricing Strategies Legislation Pricing Debate Policy Government Payers Politics BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.